Zdrowie i gospodarka · 20.01.1995
Adverse Experience Reporting Requirements for Human Drug; Correction
The Food and Drug Administration (FDA) is correcting a proposed rule that appeared in the Federal Register of October 27, 1994 (59 FR 54046). The document proposed to amend its current adverse experience reporting regulations for human drug products and for licensed biological products. The document was published with an error in the codified section. This document corrects that error.